文献速递药疹与重症皮肤不良反应

美国儿童Stevens-Johnson综合征与中毒性表皮坏死松解症的疾病负担

Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States.
PubMed 文献 · J Am Acad Dermatol · 2017-03-09

本研究基于2009至2012年美国全国住院患者样本中20%的代表性样本,分析儿童SJS/TEN的发病率、死亡率、住院时长和费用。结果显示SJS、SJS-TEN和TEN的年发病率分别为每百万儿童5.3、0.8和0.4例,死亡率分别为0%、4%和16%,且住院时间和费用显著高于其他住院。

要点

  • 儿童SJS/TEN总体发病率低,但TEN死亡率高达16%。
  • SJS、SJS-TEN、TEN的住院时长和费用均显著高于其他住院。
  • 肾衰竭、恶性肿瘤、败血症、细菌感染和癫痫是死亡的预测因素。

核心结论

  • 儿童SJS/TEN在美国造成显著的疾病负担,TEN死亡率高。

研究设计与样本

  • 横断面研究,使用2009至2012年全国住院患者样本中20%的代表性样本。

主要发现

  • SJS、SJS-TEN、TEN的年发病率分别为每百万儿童5.3、0.8、0.4例。
  • SJS住院时长9.4±0.6天、费用$24,947±$3171;SJS-TEN 15.7±1.5天、$63,787±$8014;TEN 20.4±6.3天、$102,243±$37,588;其他住院4.6±0.1天、$10,496±$424。
  • 死亡率:SJS为0%,SJS-TEN为4%,TEN为16%。
  • 死亡预测因素包括肾衰竭(aOR 300.28,95%CI 48.59->999.99)、恶性肿瘤(aOR 54.33,95%CI 9.40-314.22)、败血症(aOR 30.45,95%CI 7.91-117.19)、细菌感染(aOR 20.38,95%CI 5.44-76.36)、癫痫(aOR 5.56,95%CI 1.37-26.2)。

临床怎么用

  • 临床医生应认识到儿童SJS/TEN可导致高死亡率,尤其TEN死亡率达16%。
  • 对于合并肾衰竭、恶性肿瘤、败血症、细菌感染或癫痫的患儿,应警惕死亡风险升高。

局限性

  • 数据中未包含治疗信息。
  • 合并症的诊断日期缺失,无法进行时间性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the epidemiology of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in children. OBJECTIVE: We sought to determine the morbidity, mortality, and comorbid health conditions of SJS and TEN in US children. METHODS: This was a cross-sectional study of the 2009 to 2012 Nationwide Inpatient Sample, which contains a representative 20% sample of all US hospitalizations. Sociodemographics, inflation-adjusted cost, length of stay, comorbidities, and mortality were analyzed using descriptive statistics and multivariate regression analyses. RESULTS: The incidences of SJS, SJS-TEN, and TEN were a mean 5.3, 0.8, and 0.4 cases per million children per year in the US, respectively. Prolonged length of stay and higher costs of care (SJS: 9.4 ± 0.6 days, $24,947 ± $3171; SJS-TEN: 15.7 ± 1.5 days, $63,787 ± $8014; TEN: 20.4 ± 6.3 days, $102,243 ± $37,588) were observed compared with all other admissions (4.6 ± 0.1 days, $10,496 ± $424). Mortality was 0% for SJS, 4% for SJS-TEN, and 16% for TEN. In regression models, predictors of mortality included renal failure (adjusted OR [aOR] 300.28, 95% confidence interval [CI] 48.59->999.99), malignancy (aOR 54.33, 95% CI 9.40-314.22), septicemia (aOR 30.45, 95% CI 7.91-117.19), bacterial infection (aOR 20.38, 95% CI 5.44-76.36), and epilepsy (aOR 5.56, 95% CI 1.37-26.2). LIMITATIONS: Data regarding treatment were not available. Date of diagnosis of comorbidities was not present, precluding temporal analysis. CONCLUSIONS: Pediatric SJS/TEN poses a substantial health burden in the United States.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Hsu DY, Brieva J, Silverberg NB, et al. Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. J Am Acad Dermatol. 2017. PMID: 28285784. doi:10.1016/j.jaad.2016.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。